z-logo
open-access-imgOpen Access
A 2-Hydroxyisoquinoline-1,3-Dione Active-Site RNase H Inhibitor Binds in Multiple Modes to HIV-1 Reverse Transcriptase
Author(s) -
Karen A. Kirby,
Nataliya Myshakina,
Martin T. Christen,
Yue-Lei Chen,
Hilary A. Schmidt,
Andrew D. Huber,
Zhaoyong Xi,
Seongmi Kim,
Rohit Rao,
Skyler T. Kramer,
Qiongying Yang,
Kamalendra Singh,
Michael A. Parniak,
Zhengqiang Wang,
Rieko Ishima,
Stefan G. Sarafianos
Publication year - 2017
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01351-17
Subject(s) - reverse transcriptase , rnase h , active site , ic50 , microbiology and biotechnology , stereochemistry , human immunodeficiency virus (hiv) , binding site , rnase p , chemistry , enzyme , polymerase , biology , virology , biochemistry , in vitro , rna , gene
The RNase H (RNH) function of HIV-1 reverse transcriptase (RT) plays an essential part in the viral life cycle. We report the characterization of YLC2-155, a 2-hydroxyisoquinoline-1,3-dione (HID)-based active-site RNH inhibitor. YLC2-155 inhibits both polymerase (50% inhibitory concentration [IC50 ] = 2.6 μM) and RNH functions (IC50 = 0.65 μM) of RT but is more effective against RNH. X-ray crystallography, nuclear magnetic resonance (NMR) analysis, and molecular modeling were used to show that YLC2-155 binds at the RNH-active site in multiple conformations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom